Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2013
03/19/2013CA2311647C Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
03/19/2013CA2195334C Compositions and methods for enhanced tumor cell immunity in vivo
03/14/2013WO2013036973A2 Methods and compositions for controlling assembly of viral proteins
03/14/2013WO2013036914A1 Materials and methods for modulating immune responses
03/14/2013WO2013036902A1 Submicron particles to decrease transfusion
03/14/2013WO2013036889A1 Retrograde transport peptide and use of same for delivery to central nervous system
03/14/2013WO2013036879A1 Compositions and methods for treating prostate cancer
03/14/2013WO2013036875A1 Ceramidase and cell differentiation
03/14/2013WO2013036840A2 Peptide inhibitors of caspase 2 activation
03/14/2013WO2013036799A2 Methods and compositions involving nkg2d inhibitors and cancer
03/14/2013WO2013036720A1 Methods for treatment of cancer by targeting sirt5
03/14/2013WO2013036622A2 Antiviral peptides effective against hepatitis c virus
03/14/2013WO2013036403A1 TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES
03/14/2013WO2013036383A1 Oral delivery for hemoglobin based oxygen carriers
03/14/2013WO2013036303A2 Induced tolerogenic dendritic cells to reduce systemic inflammatory cytokines
03/14/2013WO2013036297A1 Therapeutic protein-specific induced tolerogenic dendritic cells and methods of use
03/14/2013WO2013036282A2 Downregulation of inflammatory micrornas by ilt3
03/14/2013WO2013036208A1 P53 activating peptides
03/14/2013WO2013036201A1 Polypeptide vaccine
03/14/2013WO2013036032A1 A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate
03/14/2013WO2013035931A1 Peptide inhibiting matrix metalloproteanases activity and use thereof
03/14/2013WO2013035906A1 Method for preventing and treating salmonella typhimurium infection
03/14/2013WO2013035896A1 Novel uses of kiaa1764 as apoptosis and aging regulator
03/14/2013WO2013035895A1 Novel apoptosis regulator
03/14/2013WO2013035107A1 Therapeutic peptides
03/14/2013WO2013034982A2 Immunomodulatory peptides for treatment of progressive neurodegenerative diseases
03/14/2013WO2013034805A1 Neuroprotective cell-penetrating peptides
03/14/2013WO2013034795A1 Peptide secreted by lactobacillus plantarum with immunomodulating function
03/14/2013WO2013034749A1 Polypeptides targeting glycosylated muc2 proteins, methods of synthesis, their nucleic acids and uses thereof
03/14/2013WO2013034670A1 Preparation of micafungin intermediates
03/14/2013WO2013034546A1 Fish-protein hydrolysates used in preventing and/or treating metabolic disorders such as metabolic syndrome particularly associated with obesity
03/14/2013WO2013034157A1 Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain
03/14/2013WO2013034116A1 Vascular endothelial myostatin mutant that mutates at atp binding sites
03/14/2013WO2013006762A3 Multiple-enzyme nanocomplexes
03/14/2013WO2012178160A3 Materials and methods for modulating immune responses
03/14/2013WO2012173422A9 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
03/14/2013WO2012170842A3 Peptide for protection of allergic respiratory disorders
03/14/2013WO2012170392A3 Shk-based pharmaceutical compositions and methods of manufacturing and using the same
03/14/2013WO2012169892A3 The use of alkaline phosphatase for preserving renal function
03/14/2013WO2012162089A3 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth
03/14/2013WO2012148200A9 Composition for aiding surgical procedures for treating ischemic vascular diseases
03/14/2013WO2012144778A9 Surface-active collagen barrier membrane to which a peptide is bound
03/14/2013WO2012143477A3 Anticancer fusion protein
03/14/2013WO2012141794A3 Crystal structure and peptide inhibitors of hausp deubiquitinase
03/14/2013WO2012138846A3 Method and compositions comprising small rna agonist and antagonists to modulate inflammation
03/14/2013WO2012138691A3 Diagnosis and treatment of taxane-resistant cancers
03/14/2013WO2012135528A3 Galectin-3c combination therapy for human cancer
03/14/2013WO2012135177A3 Methods and compositions for cytomegalovirus il-10 protein
03/14/2013WO2012123959A3 Copolymer-1, process for preparation and analytical methods thereof
03/14/2013WO2012120532A3 Cyclic short chain pth analog peptides
03/14/2013WO2012115771A3 Systems and methods for therapy of kidney disease and/or heart failure using chimeric natriuretic peptides
03/14/2013WO2012115715A3 Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use
03/14/2013WO2012044671A3 Method for removing residual organic solvent from microparticles
03/14/2013US20130067608 Colon cancer targets and uses thereof
03/14/2013US20130067607 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof
03/14/2013US20130067604 Method of Treatment or Prevention of Hair Loss or for the Enhancement of Hair Growth
03/14/2013US20130066052 Ucp4
03/14/2013US20130065961 Modulation of physiological processes and agents useful for same
03/14/2013US20130065869 Ophthalmologic irrigation solutions and method
03/14/2013US20130065841 Process for a folate-targeted agent
03/14/2013US20130065840 Method and peptide for regulating cellular activity
03/14/2013US20130065839 Treatment of t-cell mediated diseases
03/14/2013US20130065838 Sap variants and their use
03/14/2013US20130065837 Integrin interaction inhibitors for the treatment of cancer
03/14/2013US20130065836 Biomarker for gastric cancer
03/14/2013US20130065835 Prognostic tests for development of dermal stretch marks and implications for the preventative treatment thereof
03/14/2013US20130065834 Modulators of proteasome activity
03/14/2013US20130065833 Alkylated sp-b peptoid compounds and related lung surfactant compositions
03/14/2013US20130065832 Composition and methods for reducing opioid-induced pruritis
03/14/2013US20130065831 Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)
03/14/2013US20130065830 Dopamine Neuron Stimulating Peptide-11 Protection From Complex 1 Mitochondrial Inhibitors
03/14/2013US20130065829 Peptides and supported peptides for treating skin diseases
03/14/2013US20130065828 Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
03/14/2013US20130065827 Crystalline Peptide Epoxyketone Immunoproteasome Inhibitor
03/14/2013US20130065826 Injectable solution at pH 7 Comprising at least one basal insulin whose PI is between 5.8 and 8.5
03/14/2013US20130065825 Compositions and Methods for Delaying Senescence or Cell Death in Neurons
03/14/2013US20130065824 Controlling the texture of high-protein nutritional compositions comprising micellar casein
03/14/2013US20130065823 Supplement for Strengthening the Muscles of a Human
03/14/2013US20130065822 Compositions for masking the flavor of nutrients and methods for making same
03/14/2013US20130065821 Composition for preventing and improving metabolic syndrome
03/14/2013US20130065820 Synthetic myostatin peptide antagonists
03/14/2013US20130065819 Target of egr1 (toe1) polypeptides for inhibition of hiv
03/14/2013US20130065818 Arylamide Compounds And Compositions And Uses Thereof
03/14/2013US20130065817 Polypeptide acting to enhance ischemic diseases
03/14/2013US20130065816 Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use
03/14/2013US20130065815 Fn 14/TRAIL Fusion Proteins
03/14/2013US20130065814 Inductive production of pluripotent stem cells using synthetic transcription factors
03/14/2013US20130065298 siRNA-MEDIATED GENE SILENCING
03/14/2013US20130064905 Method for Enhancing the Growth and Fullness of Hair
03/14/2013US20130064895 Amphiphilic Peptides and Peptide Particles
03/14/2013US20130064886 Microtablets for Drug Delivery
03/14/2013US20130064882 Compositions and Methods for the Prevention of Cancer in High Risk Patients
03/14/2013US20130064879 Compositions and Methods for Inhibiting Viral Replication
03/14/2013US20130064866 Pulmonary and nasal delivery of serum amyloid p
03/14/2013US20130064865 Therapy to reduce extravasation damage
03/14/2013US20130064864 Submicron particles to decrease transfusion
03/14/2013US20130064844 Non-splicing variants of gp350/220
03/14/2013US20130064835 Rage regulates rock activity in cardiovascular disease
03/14/2013US20130064833 Monitoring and Modulating HGF/HGFR Activity
03/14/2013US20130064828 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease
1 ... 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 ... 3163